SeqWright to Use 454, NimbleGen Tools in Eli Lilly Collaboration

SeqWright will use the sequencing and sequence capture technologies to identify disease variants.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.